Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-131093

General Counsel bought 15,000 shares at $0.60 ($9,000)

From the SEC's structured data for this filing

Trades in this filing

Samuel George A. III · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-26 Purchase : show line 1 in the form +15,000 $0.60 $9,000 22,184 D
Open-market purchases · 15,000 sh · avg $0.60 · $9,000
Loading xslF345X05/ownership.xml…